SEC EDGAROCT 151 min read$SNEX

Maurer Mark Lowry sold $3.2M of SNEX

Maurer Mark Lowry sold 52,953 shares of StoneX Group Inc. (SNEX) at $60.35 ($3.20M total) on 2026-10-12 under a Rule 10b5-1 trading plan.

Original reporting

SEC EDGAR · Maurer Mark Lowry

Published Oct 15, 2026, 12:00 AM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 15, 2026, 12:01 AM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$SNEX

Bearish

medium confidence

Mentioned

$SNEX

Relevance

5/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$SNEXBearishLow

Why it matters

The transaction reduces the insider's ownership and may be interpreted as a lack of confidence, prompting modest sell‑side pressure.

Market read

While the sale is not large enough to move the stock dramatically, it provides fresh insider information that traders may consider when assessing short‑term sentiment.

What to watch

Potential upcoming corporate actions or market conditions that prompted the 10b5‑1 execution.

Relevance 5/10Novelty 5/10Timing: post‑market filing on Oct 14

Background

SEC Form 4 filing discloses an insider's open‑market sale under a pre‑arranged 10b5‑1 plan.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$SNEXBearishMedium confidence

Context

Insider Mark Lowry sold 52,953 shares for $3.2M via a 10b5‑1 plan, reducing his stake to 219,663 shares.

Expected impact

likely slight downward pressure as the market prices the insider sell.

Evidence & confidence

A $3.2M insider sale is material for a mid‑cap stock but not large enough to trigger a sharp move; investors may view it as a cautionary signal.

Market effects

Sector

Minimal impact on the broader brokerage/financial services sector.

Regional

Limited to U.S. investors tracking StoneX Group.

Global

None

Counterpoint

What could challenge this read

The sale could be routine under a pre‑arranged plan and not indicative of negative fundamentals.

Key entities

company
StoneX Group Inc.
U.S. listed brokerage and financial services firm (ticker SNEX).
insider
Maurer Mark Lowry
Officer/director of StoneX Group executing a 10b5‑1 sale.

Read at source ← All news

OCT 22

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

investing.com2 min

OCT 19

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

investing.com2 min

OCT 16

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

investing.com1 min

OCT 15

$ONMed

Onsemi started at Buy at StoneX, sees 54% upside on chip growth (ON:NASDAQ)

StoneX initiated coverage of ON Semiconductor (ON) with a Buy rating, citing potential benefits from semiconductor demand recovery and growth in automotive and AI data center power systems. The stock is down 3% in premarket trading.

seekingalpha.com1 min

OCT 15

$ONMed

ON Stock Draws Bullish Initiation From StoneX — Analyst Sees Nearly 50% Upside On Broadening Chip Recovery

Onsemi (ON) guided Q3 revenue between $1.65B and $1.75B, up from $1.6B in Q2. StoneX initiated coverage with a bullish outlook, suggesting nearly 50% upside. Retail sentiment on Stocktwits is 'extremely bearish,' despite a 29% year-to-date rally for ON shares, compared to a 65% rise in the iShares Semiconductor ETF (SOXX).

finance.yahoo.com1 min

OCT 14

$DPZMed

StoneX maintains Buy rating on Domino's Pizza, $400 price target

StoneX maintained a Buy rating on Domino's Pizza (DPZ) with a $400 price target, implying a 35.1% upside from the Oct 13 close. The firm cited strong traffic growth drivers and attractive valuation relative to historical ranges. Recent analyst price targets for DPZ range from $320 to $425.

tradingview.com1 min